1-5 of 5
Authors: Nira Hadar
Journal Article
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial Free
Neuro-Oncology, Volume 24, Issue 6, June 2022, Pages 951–963, https://doi.org/10.1093/neuonc/noab271
Published: 26 November 2021
Journal Article
CTIM-20. FINAL RESULTS OF CONTROLLED IL-12 MONOTHERAPY AND IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi54, https://doi.org/10.1093/neuonc/noab196.212
Published: 12 November 2021
Journal Article
CTIM-05. COMBINATION OF CONTROLLED INTERLEUKIN-12 GENE THERAPY WITH IMMUNE CHECKPOINT BLOCKADE IN RECURRENT GLIOBLASTOMA: UPDATED RESULTS OF A MULTI-INSTITUTIONAL, OPEN LABEL PHASE 1 TRIAL Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii33, https://doi.org/10.1093/neuonc/noaa215.139
Published: 09 November 2020
Journal Article
CTIM-27. PHASE I/II STUDY OF CONTROLLED IL-12 AS IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii39, https://doi.org/10.1093/neuonc/noaa215.161
Published: 09 November 2020
Journal Article
CTIM-28. PHASE 2 TRIAL OF CONTROLLED IL-12 IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA (rGBM) Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii39, https://doi.org/10.1093/neuonc/noaa215.162
Published: 09 November 2020
